Lung Clearance Index in Adults and Children With Cystic Fibrosis

Chest

Volumn 150, Issue 6, 2016, Pages 1323-1332

  O'Neill, Katherine ^a   Tunney, Michael M ^b   Johnston, Elinor ^a   Rowan, Stephen ^c   Downey, Damian G ^d   Rendall, Jacqueline ^d   Reid, Alastair ^d   Bradbury, Ian ^e   Elborn, J Stuart ^a   Bradley, Judy M ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c SOUTH EASTERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

^d ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^e FRONTIER SCIENCE SCOTLAND LTD   (United Kingdom)

Author keywords

cystic fibrosis; lung clearance index; outcome measure

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY IMAGE; BODY WEIGHT; BREATH ANALYSIS; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS QUESTIONNAIRE-REVISED; DIAGNOSTIC TEST ACCURACY STUDY; EATING DISORDER; FEASIBILITY STUDY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL DISEASE; HUMAN; LUNG CLEARANCE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT REPEATABILITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT DISEASE; SENSITIVITY AND SPECIFICITY; SPIROMETRY; ADOLESCENT; BIOASSAY; CASE CONTROL STUDY; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; PRESCHOOL CHILD; STANDARDS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; ENDPOINT DETERMINATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; RESPIRATORY FUNCTION TESTS; SENSITIVITY AND SPECIFICITY; SPIROMETRY; SURVEYS AND QUESTIONNAIRES;

EID: 85002866942     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.06.029     Document Type: Article

References (44)

1. 1 Fuchs, S.I., Gappa, M., Lung clearance index: clinical and research applications in children. Paediatr Respir Rev 12:4 (2011), 264–270.
2. 2 Kent, L., Reix, P., Innes, J.A., et al. Lung clearance index: evidence for use in clinical trials in cystic fibrosis. J Cyst Fibros 13:2 (2014), 123–138.
3. 3 Belessis, Y., Dixon, B., Hawkins, G., et al. Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index. Am J Respir Crit Care Med 185:8 (2012), 862–873.
4. 4 Aurora, P., Gustafsson, P., Bush, A., et al. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax 59:12 (2004), 1068–1073.
5. 5 Singer, F., Kieninger, E., Abbas, C., et al. Practicability of nitrogen multiple-breath washout measurements in a pediatric cystic fibrosis outpatient setting. Pediatr Pulmonol 48:8 (2013), 739–746.
6. 6 Amin, R., Subbarao, P., Jabar, A., et al. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax 65:5 (2010), 379–383.
7. 7 Owens, C.M., Aurora, P., Stanojevic, S., et al. Lung clearance index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 66:6 (2011), 481–488.
8. 8 Gustafsson, P.M., De Jong, P.A., Tiddens, H.A., Lindblad, A., Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 63:2 (2008), 129–134.
9. 9 Hall, G.L., Logie, K.M., Parsons, F., et al. Air trapping on chest CT is associated with worse ventilation distribution in infants with cystic fibrosis diagnosed following newborn screening. PLoS One, 6(8), 2011, e23932.
10. 10 Hoo, A.F., Thia, L.P., Nguyen, T.T.D., et al. Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening. Thorax 67:10 (2012), 874–881.
11. 11 Aurora, P., Stanojevic, S., Wade, A., et al. Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med 183:6 (2011), 752–758.
12. 12 Aurora, P., Bush, A., Gustafsson, P., et al. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 171:3 (2005), 249–256.
13. 13 Gustafsson, P.M., Aurora, P., Lindblad, A., Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J 22:6 (2003), 972–979.
14. 14 Aurora, P., Multiple-breath inert gas washout test and early cystic fibrosis lung disease. Thorax 65:5 (2010), 373–374.
15. 15 Vermeulen, F., Proesmans, M., Boon, M., Havermans, T., De Boeck, K., Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis. Thorax 69:1 (2014), 39–45.
16. 16 Subbarao, P., Stanojevic, S., Brown, M., et al. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline. Am J Respir Crit Care Med 188:4 (2013), 456–460.
17. 17 Amin, R., Subbarao, P., Lou, W., et al. The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. Eur Respir J 37:4 (2011), 806–812.
18. 18 Davies, J., Sheridan, H., Bell, N., et al. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial. Lancet Respir Med 1:8 (2013), 630–638.
19. 19 Horsley, A.R., Gustafsson, P.M., Macleod, K.A., et al. Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax 63:2 (2008), 135–140.
20. 20 Verbanck, S., Paiva, M., Paeps, E., et al. Lung clearance index in adult cystic fibrosis patients: the role of convection-dependent lung units. Eur Respir J 42:2 (2013), 380–388.
21. 21 Fuchs, S.I., Gappa, M., Eder, J., Unsinn, K.M., Steinkamp, G., Ellemunter, H., Tracking lung clearance index and chest CT in mild cystic fibrosis lung disease over a period of three years. Respir Med 108:6 (2014), 865–874.
22. 22 Ellemunter, H., Fuchs, S.I., Unsinn, K.M., et al. Sensitivity of Lung clearance index and chest computed tomography in early CF lung disease. Respir Med 104:12 (2010), 1834–1842.
23. 23 Rosenfeld, M., An overview of endpoints for cystic fibrosis clinical trials: one size does not fit all. Proc Am Thorac Soc 4:4 (2007), 299–301.
24. 24 Simmonds, N.J., D'Souza, L., Roughton, M., Alton, E.W., Davies, J.C., Hodson, M.E., Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane conductance regulator function. Eur Respir J 37:5 (2011), 1076–1082.
25. 25 Subbarao, P., Milla, C., Aurora, P., et al. Multiple-breath washout as a lung function test in cystic fibrosis. A Cystic Fibrosis Foundation workshop report. Ann Am Thorac Soc 12:6 (2015), 932–939.
26. 26 Horsley, A.R., Macleod, K.A., Robson, A.G., et al. Effects of cystic fibrosis lung disease on gas mixing indices derived from alveolar slope analysis. Respir Physiol Neurobiol 162:3 (2008), 197–203.
27. 27 O'Neill, K., Bradley, J.M., Tunney, M., Elborn, J.S., S44 Lung clearance index (LCI) and FEV1 correlate equally with treatment burden as measured by cystic fibrosis questionnaire-revised (CFQ-R). Thorax, 66, 2011, A23.
28. 28 O'Neill, K., Johnston, E., Tunney, M., Elborn, J.S., Bradley, J.M., 159 lung clearance index (LCI) during and following a pulmonary exacerbation (PEx) in patients with CF. J Cyst Fibros, 11, 2012, S97.
29. 29 O'Neill, K., Johnston, E., Tunney, M., Elborn, J.S., Bradley, J.M., WS7.3 relationships between lung clearance index (LCI), patient reported symptoms and health related quality of life (HRQoL) in CF. J Cyst Fibros, 11, 2012, S14.
30. 30 Rosenstein, B.J., Cutting, G.R., The diagnosis of cystic fibrosis: A consensus statement. J Pediatr 132:4 (1998), 589–595.
31. 31 Miller, M.R., Hankinson, J., Brusasco, V., et al. Standardisation of spirometry. Eur Respir J 26:2 (2005), 319–338.
32. 32 Stanojevic, S., Wade, A., Stocks, J., et al. Reference ranges for spirometry across all ages. Am J Respir Crit Care Med 177:3 (2008), 253–260.
33. 33 Amin, R., Stanojevic, S., Kane, M., Webster, H., Ratjen, F., A randomized controlled trial to evaluate the lung clearance index as an outcome measure for early phase studies in patients with cystic fibrosis. Respir Med 112 (2016), 59–64.
34. 34 Venkatraman, E.S., A permutation test to compare receiver operating characteristic curves. Biometrics 56:4 (2000), 1134–1138.
35. 35 Lee, T.W.R., Brownlee, K.G., Conway, S.P., Denton, M., Littlewood, J.M., Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cystic Fibrosis 2:1 (2003), 29–34.
36. 36 Bland, J.M., Altman, D.G., Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:8476 (1986), 307–310.
37. 37 Brown, M., Jensen, R., Balkovec, S., et al. Anonymous effects of forced expiratory maneuvers and bronchodilator on lung clearance index in infants. Am J Respir Crit Care Med, 183, 2011, A6311.
38. 38 Fuchs, S.I., Toussaint, S., Edlhaimb, B., Ballmann, M., Gappa, M., Short-term effect of physiotherapy on variability of the lung clearance index in children with cystic fibrosis. Pediatr Pulmonol 45:3 (2010), 301–306.
39. 39 Kieninger, E., Singer, F., Fuchs, O., et al. Long-term course of lung clearance index between infancy and school-age in cystic fibrosis subjects. J Cyst Fibros 10:6 (2011), 487–490.
40. 40 Simpson, S.J., Ranganathan, S., Park, J., et al. Progressive ventilation inhomogeneity in infants with cystic fibrosis after pulmonary infection. Eur Respir J 46:6 (2015), 1680–1690.
41. 41 Nguyen, T.T., Thia, L.P., Hoo, A.F., et al. Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants. Thorax 69:10 (2014), 910–917.
42. 42 Sawicki, G.S., Ren, C.L., Konstan, M.W., et al. Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes. J Cyst Fibros 12:5 (2013), 461–467.
43. 43 Quittner, A.L., Buu, A., Messer, M.A., Modi, A.C., Watrous, M., Development and validation of the Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 128:4 (2005), 2347–2354.
44. 44 Singer, F., Houltz, B., Latzin, P., Robinson, P., Gustafsson, P., A realistic validation study of a new nitrogen multiple-breath washout system. PLoS One, 7(4), 2012, e36083.